Seattle, Aug. 10, 2022 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global veterinary antibiotics market is estimated to be valued at US$ 1.43 billion in 2022 and is expected to exhibit a CAGR of 3.8% during the forecast period (2022-2030).
Key Trends and Analysis of the Global Veterinary Antibiotics Market:
Major players operating in the market are focusing on adopting growth strategies such as technological advancements and new product approvals, which is expected to drive the market growth over the forecast period. For instance, in August 2018, Bayer launched i-COWNT BRD, a novel online comparison tool designed to help veterinarians make more informed treatment decisions for bovine respiratory disease (BRD). It is based on an independent meta-analysis comparing mixed treatments from BRD treatment studies. I-COWNT BRD simplifies scientific data analysis to enable veterinarians to select the most effective antibiotic for treatment.
Request Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2324
Key Market Takeaways:
The global veterinary antibiotics market is expected to exhibit a CAGR of 3.8% during the forecast period due to advances in pet medicine and surgery continue, there will be a increasing demand for appropriate antibiotics.
Among product type, anti-bacterial segment is expected to hold a dominant position over the forecast period, owing to benefits such as prevention and treatment of animal…
